![Dani Stoltzfus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dani Stoltzfus
Corporate Officer/Principal at NEUBASE THERAPEUTICS, INC.
Profile
Dani Stoltzfus is currently working as Vice President-Research at NeuBase Therapeutics, Inc. She has an education background from Flinders University, where she completed her undergraduate, graduate, and doctorate degrees.
Dani Stoltzfus active positions
Companies | Position | Start |
---|---|---|
NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Dani Stoltzfus
Flinders University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
NeuBase Therapeutics, Inc.
![]() NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Dani Stoltzfus